Advanced Instruments Introduces 2020-BIO Multi-Sample Osmometer as First True Automation-Friendly Osmometer for the Biopharmaceutica...( NORWOOD Mass. April 20 /- The ...)

NORWOOD, Mass. April 20 /PRNewswire/ -- Advanced Instruments, Inc. today introduced the Advanced(R) 2020-BIO Multi-Sample Osmometer as the first true automation-friendly osmometer for the biopharmaceutical industry.

"The Advanced(R) 2020-BIO Multi-Sample Osmometer is specifically designed for -- and completely redefines -- automation capabilities for osmolality testing in the biopharmaceutical laboratory," said Kelly Peterson, Product Manager, Advanced Instruments (www.aicompanies.com). "The 2020-BIO system development is in response to emerging demand in the pharmaceutical industry to integrate osmolality testing within an automated platform environment."

"Based on an extension of the industry-proven Advanced 2020 Osmometer, the 2020-BIO includes a host of features which enable fast and simple integration of the system with liquid handling robotics and laboratory automation platforms," Peterson said.

The 2020-BIO has been successfully applied to automate osmolality testing in applications ranging from cell culture process development and optimization to biopharmaceutical manufacturing and process control - It can also be extended to pharmaceutical research and drug development applications including formulation development, product stability testing, and drug safety and metabolism testing.

Major features of the new 2020-BIO include:

• Freezing point technology -- The industry-preferred method for determining sample concentration
• Automation friendly system design allows easy access for liquid handling
  '/>"/>